{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:18:29Z","timestamp":1787642309163,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.nut.2026.113325","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:05:45Z","timestamp":1781208345000},"page":"113325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of multistrain probiotic supplementation on hepatic function and anthropometric parameters in patients with metabolic dysfunction-associated steatotic liver disease: a double-blind, randomized controlled trial"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8965-6123","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Moszak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Kaczmarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1261-2664","authenticated-orcid":false,"given":"Matylda","family":"Kr\u0119gielska-Naro\u017cna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"\u0141oniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3430-9079","authenticated-orcid":false,"given":"Karolina","family":"Skonieczna-\u017bydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Szuli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Bogda\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2026.113325_bib0001","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.nut.2026.113325_bib0002","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.nut.2026.113325_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.nut.2026.113325_bib0004","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2026.113325_bib0005","first-page":"258","article-title":"Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis","volume":"10","author":"Khalid","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.nut.2026.113325_bib0006","first-page":"250","article-title":"Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"173","author":"Thomas","year":"2022","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.nut.2026.113325_bib0007","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.nut.2026.113325_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nut.2026.113325_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.nut.2026.113325_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/livers5010011","article-title":"Gut microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD): emerging pathogenic mechanisms and therapeutic implications","volume":"5","author":"Abdelhameed","year":"2025","journal-title":"Livers"},{"key":"10.1016\/j.nut.2026.113325_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.nut.2026.113325_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction\u2013associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.nut.2026.113325_bib0013","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2026.113325_bib0014","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/oby.22627","article-title":"Ratio of conjugated chenodeoxycholic to muricholic acids is associated with severity of nonalcoholic steatohepatitis","volume":"27","author":"Chen","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.nut.2026.113325_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974872","article-title":"Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nut.2026.113325_bib0016","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.3390\/nu15163588","article-title":"The microbiome, epigenome, and diet in adults with obesity during behavioral weight loss","volume":"15","author":"Hill","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2026.113325_bib0017","first-page":"1","article-title":"An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease","volume":"47","author":"Yao","year":"2025","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.nut.2026.113325_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-023-06489-2","article-title":"Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice","volume":"241","author":"Wla\u017a","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nut.2026.113325_bib0019","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2026.113325_bib0020","first-page":"71678","article-title":"Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"22","author":"Houttu","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib0021","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/oby.2011.38","article-title":"A better index of body adiposity","volume":"19","author":"Bergman","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.nut.2026.113325_bib0022","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/nu11030677","article-title":"Impact of nutritional changes on nonalcoholic fatty liver disease","volume":"11","author":"Perdomo","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2026.113325_bib0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13105-023-00991-z","article-title":"Fatty liver index (FLI): more than a marker of hepatic steatosis","volume":"80","author":"Kaneva","year":"2024","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.nut.2026.113325_bib0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5009\/gnl19301","article-title":"Hepatic steatosis index in the detection of fatty liver in patients with chronic hepatitis B receiving antiviral therapy","volume":"15","author":"Chang","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.nut.2026.113325_bib0025","article-title":"Hepatic steatosis index (HSI): a valuable biomarker in subjects with metabolic dysfunction-associated fatty liver disease (MAFLD)","volume":"29","author":"Priego-Parra","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.nut.2026.113325_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1359960","article-title":"Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantation","volume":"15","author":"Grancini","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.nut.2026.113325_bib0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib0028","doi-asserted-by":"crossref","first-page":"997018","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"8","author":"Fang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nut.2026.113325_bib0029","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/livers5010011","article-title":"Gut microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD): emerging pathogenic mechanisms and therapeutic implications","volume":"5","author":"Abdelhameed","year":"2025","journal-title":"Livers"},{"key":"10.1016\/j.nut.2026.113325_bib74","doi-asserted-by":"crossref","first-page":"1484598","DOI":"10.1155\/2019\/1484598","article-title":"Systematic review with meta-analysis: the effects of probiotics in nonalcoholic fatty liver disease","volume":"2019","author":"Xiao","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.nut.2026.113325_bib0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3920\/BM2020.0183","article-title":"Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"12","author":"Jin","year":"2021","journal-title":"Benef Microbes"},{"key":"10.1016\/j.nut.2026.113325_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.844242","article-title":"Effect of probiotics on liver enzymes in patients with non-alcoholic fatty liver disease: an umbrella of systematic review and meta-analysis","volume":"9","author":"Musazadeh","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib0067","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12876-024-03356-y","article-title":"Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.nut.2026.113325_bib73","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1097\/MS9.0000000000002276","article-title":"The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with GRADE assessment","volume":"86","author":"Maddineni","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.nut.2026.113325_bib76","doi-asserted-by":"crossref","first-page":"1470185","DOI":"10.3389\/fnut.2024.1470185","article-title":"The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"11","author":"Song","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib0035","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1038\/s41598-025-92125-2","article-title":"Probiotic Bifidobacterium bifidum strains desialylate MUC13 and increase intestinal epithelial barrier function","volume":"15","author":"Segui-Perez","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2026.113325_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2023.102026","article-title":"role of Bifidobacterium in modulating the intestinal epithelial tight junction barrier: current knowledge and perspectives","volume":"7","author":"Abdulqadir","year":"2023","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib0033","doi-asserted-by":"crossref","first-page":"G940","DOI":"10.1152\/ajpgi.00141.2009","article-title":"Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis","volume":"297","author":"Khailova","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.nut.2026.113325_bib0034","doi-asserted-by":"crossref","first-page":"eaat6975","DOI":"10.1126\/sciimmunol.aat6975","article-title":"Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells","volume":"3","author":"Verma","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.nut.2026.113325_bib0036","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1753465810379009","article-title":"Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection","volume":"4","author":"Cazzola","year":"2010","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.nut.2026.113325_bib0037","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1203\/PDR.0b013e3182096ff0","article-title":"Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats","volume":"69","author":"Dykstra","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.nut.2026.113325_bib0038","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1574-6968.2009.01781.x","article-title":"Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells","volume":"300","author":"Wine","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.nut.2026.113325_bib0039","article-title":"Intestinal barrier, immunity and gut microbiota-based protective effects of Lactococcus lactis HF08 and its postbiotic derivative on aging and aging colitis mice","volume":"197","author":"Liu","year":"2024","journal-title":"Food Res Int Ott Ont"},{"key":"10.1016\/j.nut.2026.113325_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09540100220137682","article-title":"Immunostimulatory actions of lactobacilli: mitogenic induction of antibody production and spleen cell proliferation by Lactobacillus delbrueckii subsp. bulgaricus and lactobacillus acidophilus","volume":"14","author":"Easo","year":"2002","journal-title":"Food Agric Immunol"},{"key":"10.1016\/j.nut.2026.113325_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.108002","article-title":"Lactobacillus helveticus R0052 attenuates DSS-induced colitis via modulation of gut microbiota, intestinal metabolites and immunological profiles in a mouse model","volume":"208","author":"Dong","year":"2025","journal-title":"Microb Pathog"},{"key":"10.1016\/j.nut.2026.113325_bib0042","doi-asserted-by":"crossref","first-page":"M423","DOI":"10.1111\/j.1750-3841.2009.01308.x","article-title":"Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria","volume":"74","author":"Wagar","year":"2009","journal-title":"J Food Sci"},{"key":"10.1016\/j.nut.2026.113325_bib0043","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3389\/fimmu.2017.01961","article-title":"Lactococcus lactis as a versatile vehicle for tolerogenic immunotherapy","volume":"8","author":"Cook","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nut.2026.113325_bib0044","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/foods13060957","article-title":"Probiotic properties of Lactococcus lactis strains isolated from natural whey starter cultures","volume":"13","author":"De Chiara","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.nut.2026.113325_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1757-4749-6-33","article-title":"Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis","volume":"6","author":"Luerce","year":"2014","journal-title":"Gut Pathog"},{"key":"10.1016\/j.nut.2026.113325_bib0046","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1039\/C8FO02301H","article-title":"Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: in vivo and in vitro evidence","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.nut.2026.113325_bib0047","doi-asserted-by":"crossref","first-page":"e1782","DOI":"10.1093\/nutrit\/nuae180","article-title":"Evaluation of the effect of probiotic supplementation on intestinal barrier integrity and epithelial damage in colitis disease: a systematic review","volume":"83","author":"Sivri","year":"2025","journal-title":"Nutr Rev"},{"key":"10.1016\/j.nut.2026.113325_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.635","article-title":"Anti-inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control","volume":"10","author":"Aghamohammad","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.nut.2026.113325_bib0049","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/microorganisms10071474","article-title":"Beneficial shifts in gut microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in alcoholic hepatitis","volume":"10","author":"Gupta","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.nut.2026.113325_bib0050","article-title":"Lactobacillus casei Alleviated the abnormal increase of cholestasis-related liver indices during tuberculosis treatment: a post hoc analysis of randomized controlled trial","volume":"65","author":"Xiong","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nut.2026.113325_bib0051","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s41430-020-00852-8","article-title":"Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury","volume":"75","author":"Li","year":"2021","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"10.1016\/j.nut.2026.113325_bib77","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.clnu.2017.04.021","article-title":"Effects of continuous use of probiotics before liver transplantation: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Gr\u0105t","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib0053","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.nut.2026.113325_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1499013","article-title":"Non-invasive testing in metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"Dawod","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.nut.2026.113325_bib0054","article-title":"Advancements in diagnostic and therapeutic interventions of non-alcoholic fatty liver disease: a literature review","volume":"15","author":"Chaudhry","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.nut.2026.113325_bib0055","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3748\/wjg.v30.i24.3016","article-title":"Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: long life to the old biomarker!","volume":"30","author":"Lonardo","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nut.2026.113325_bib0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nut.2026.113325_bib0057","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2026.113325_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70281","article-title":"Diagnostic performance of Fibrosis-4 index, nonalcoholic fatty liver disease fibrosis score, AST -to-platelet ratio index, and BARD score among young and older adults for the diagnosis of advanced MASLD fibrosis: a retrospective cohort study","volume":"9","author":"Lin","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.nut.2026.113325_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100873","article-title":"Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis","volume":"28","author":"Contreras","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.nut.2026.113325_bib0060","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.3350\/cmh.2024.0330","article-title":"Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis","volume":"30","author":"Han","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.nut.2026.113325_bib0061","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1007\/s11606-021-07341-z","article-title":"The association of Fibrosis-4 index scores with severe liver outcomes in primary care","volume":"37","author":"Schreiner","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.nut.2026.113325_bib0062","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases Practice Guidance on Nonalcoholic Fatty Liver Disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2026.113325_bib0063","article-title":"Prognostic utility of Fibrosis-4 index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study","volume":"36","author":"Anstee","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"10","key":"10.1016\/j.nut.2026.113325_bib78","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of histologic disease activity with progression of nonalcoholic fatty liver disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.nut.2026.113325_bib0064","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13105-023-00991-z","article-title":"Fatty liver index (FLI): more than a marker of hepatic steatosis","volume":"80","author":"Kaneva","year":"2024","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.nut.2026.113325_bib0065","first-page":"1224","article-title":"Optimal probiotic combinations for treating nonalcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"43","author":"Yang","year":"2024","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.nut.2026.113325_bib0066","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/nutrit\/nuad086","article-title":"The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis","volume":"82","author":"Amini-Salehi","year":"2024","journal-title":"Nutr Rev"},{"key":"10.1016\/j.nut.2026.113325_bib0068","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12876-024-03424-3","article-title":"The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt","volume":"24","author":"Abd El Hamid","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.nut.2026.113325_bib0069","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.tjnut.2023.05.019","article-title":"Probiotic supplementation, hepatic fibrosis, and the microbiota profile in patients with nonalcoholic steatohepatitis: a randomized controlled trial","volume":"153","author":"Escouto","year":"2023","journal-title":"J Nutr"},{"key":"10.1016\/j.nut.2026.113325_bib79","doi-asserted-by":"crossref","first-page":"100810","DOI":"10.1016\/j.crfs.2024.100810","article-title":"Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: a meta-analysis of randomized controlled trials","volume":"9","author":"Cao","year":"2024","journal-title":"Curr Res Food Sci"},{"issue":"32","key":"10.1016\/j.nut.2026.113325_bib80","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021464","article-title":"Protective effect of probiotics in patients with non-alcoholic fatty liver disease","volume":"99","author":"Cai","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.nut.2026.113325_bib81","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032734","article-title":"Efficacy of probiotics on nonalcoholic fatty liver disease: a meta-analysis","volume":"102","author":"Zhou","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nut.2026.113325_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.634897","article-title":"Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics","volume":"8","author":"Liu","year":"2022","journal-title":"Front Nutr"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900726002339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900726002339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:18:51Z","timestamp":1787638731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900726002339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":78,"alternative-id":["S0899900726002339"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2026.113325","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of multistrain probiotic supplementation on hepatic function and anthropometric parameters in patients with metabolic dysfunction-associated steatotic liver disease: a double-blind, randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2026.113325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113325"}}